← back to search

Maureen P. Martin

Center for Cancer Research · US
Area of research
Immunology · Virology
Research interest
Research interests include Immune Cell Function and Interaction, T-cell and B-cell Immunology, HIV Research and Treatment, and Reproductive System and Pregnancy.
h-index
59
citations
19,121
works
162
NIH funding
primary concept
Biology
email

Recent publications

HIV post-treatment controllers have distinct immunological and virological features
Proceedings of the National Academy of Sciences 2023cited by 63position: middledoi
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis
Gastroenterology 2023cited by 16position: middledoi
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
Cancer Cell 2022cited by 121position: middledoi
Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers
Science Translational Medicine 2021cited by 101position: middledoi
HLA Alleles B*53:01 and C*06:02 Are Associated With Higher Risk of P. falciparum Parasitemia in a Cohort in Uganda
Frontiers in Immunology 2021cited by 18position: middledoi
Association of Inhibitory Killer Cell Immunoglobulin-like Receptor Ligands With Higher <i>Plasmodium falciparum</i> Parasite Prevalence
The Journal of Infectious Diseases 2020cited by 11position: middledoi
CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome
Nature Immunology 2019cited by 101position: middledoi
Elevated <i>HLA-A</i> expression impairs HIV control through inhibition of NKG2A-expressing cells
Science 2018cited by 152position: middledoi
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8 <sup>+</sup> T cell–mediated control of HIV-1, HCV, and HTLV-1
Science Immunology 2018cited by 69position: middledoi
Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease
PLoS Genetics 2012cited by 75position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mary Carrington · Cancer Institute (WIA)4 papers (2012–2021)Jean Digitale · University of California, San Francisco2 papers (2020–2021)Grant Dorsey · Universidad Católica de Santa Fe2 papers (2020–2021)Isabel Rodríguez-Barraquer · Global Solutions for Infectious Diseases2 papers (2020–2021)Perri C. Callaway · San Francisco General Hospital2 papers (2020–2021)Emmanuel Arinaitwe · Makerere University2 papers (2020–2021)Steven G. Deeks · University of California, San Francisco2 papers (2012–2021)Margaret E. Feeney · San Francisco General Hospital2 papers (2020–2021)John Rek · Africa Center2 papers (2020–2021)Mathias Viard · Frederick National Laboratory for Cancer Research2 papers (2020–2021)Moses R. Kamya · Universidad Católica de Santa Fe2 papers (2020–2021)George W. Nelson · Center for Cancer Research2 papers (2020–2021)Jeffrey N. Martin · Global Solutions for Infectious Diseases1 papers (2012–2012)A. Bowcock · Human Genome Sciences (United States)1 papers (2012–2012)Marcelo Fernández-Viña · Palo Alto University1 papers (2012–2012)Bruce D. Walker · Active Technologies (Italy)1 papers (2021–2021)Mathias Lichterfeld · Harvard University1 papers (2021–2021)Tami V. Wong · University of California, San Francisco1 papers (2012–2012)Ce Gao · Japan Advanced Institute of Science and Technology1 papers (2021–2021)Toby Maurer · Indiana University School of Medicine1 papers (2012–2012)